Mandi Inc. is a leading player in China’s hair loss treatment market. Our flagship “Mandi” brand has ranked #1 by retail sales value in both China’s anti-hair loss drug and minoxidil markets for ten consecutive years since 2014, capturing a 70.6% share of the minoxidil market in 2024 with cumulative sales surpassing 50 million bottles. On the R&D front, we have built comprehensive in-house capabilities anchored by five integrated platforms spanning early target discovery to clinical development. Commercially, we operate an omnichannel network covering around 2,000 hospitals and 190,000 pharmacies. Backed by a sales and marketing team of over 80 professionals, approximately 90% of whom are ex...
